Related Experiment Video
Updated: Mar 2, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by
Y Murase1, N Okahashi, T Koseki
1Department of Periodontology, Aichi Gakuin University, Nagoya, Japan.
Abstract:
Bone tissues reportedly contain considerable amounts of activin A and follistatin, an activin A-binding protein. In the present study, we found that follistatin strongly inhibited osteoclast formation in cocultures of mouse bone marrow cells and primary osteoblasts induced by 1alpha,25 dihydroxyvitamin D(3), prostaglandin E(2), and interleukin-1alpha. Antibody aganist activin A also inhibited the osteoclast formation. Furthermore, activin A synergistically stimulated osteoclast differentiation mediated by receptor activator NF-kappaB ligand (RANKL). RT-PCR analysis revealed that osteoblasts produced not only activin A but also follistatin. Western blot analysis of a panel of phosphorylated proteins revealed that activin A stimulated the phosphorylation of p44/42 mitogen activated protein (MAP) kinase (ERK1/2) and p38 MAP kinase in macrophage colony-stimulating factor-dependent bone marrow macrophages (M-BMMPhis). In addition, phosphorylation of Smad2 was observed in M-BMMPhis stimulated with activin A. These findings indicate that the phosphorylation of p44/42 MAP kinase, p38 MAP kinase, and Smad2 is involved in activin A-enhanced osteoclast differentiation induced by RANKL. Taken together, these results suggest that both activin A and follistatin produced by osteoblasts may play an important role in osteoclast differentiation through MAP kinases and Smad2 signaling pathways.
Insights
Osteoblasts produce activin A and follistatin, which regulate bone remodeling. Activin A promotes osteoclast formation via MAP kinase and Smad2 pathways, while follistatin inhibits it, suggesting a role in bone health.
Area of Science:
- Bone biology
- Cell signaling
- Endocrinology
Background:
- Bone tissues contain activin A and follistatin.
- Osteoclast differentiation is crucial for bone remodeling.
Purpose of the Study:
- To investigate the roles of activin A and follistatin in osteoclast differentiation.
- To elucidate the signaling pathways involved in activin A-mediated osteoclastogenesis.
Main Methods:
- Cocultures of mouse bone marrow cells and osteoblasts.
- Stimulation with 1alpha,25 dihydroxyvitamin D(3), prostaglandin E(2), and interleukin-1alpha.
- RT-PCR, Western blot analysis, and antibody neutralization.
Main Results:
- Follistatin and anti-activin A antibody inhibited osteoclast formation.
- Activin A synergistically stimulated osteoclast differentiation via RANKL.
- Activin A induced phosphorylation of ERK1/2, p38 MAP kinase, and Smad2 in bone marrow macrophages.
Conclusions:
- Osteoblast-derived activin A and follistatin play significant roles in osteoclast differentiation.
- MAP kinase and Smad2 signaling pathways are involved in activin A-enhanced osteoclastogenesis.
- These findings contribute to understanding bone remodeling regulation.
Related Concept Videos
Bone Remodeling
TGF - β Signaling Pathway
Osteoclasts in Bone Remodeling
The JAK-STAT Signaling Pathway
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

